Stock Alert: Fulgent Genetics Gains 18% On Launching At-home Covid-19 Test

Shares of Fulgent Genetics, Inc. (FLGT) climbed $3 or 18.18% Tuesday after-hours after the genetic testing services company said it launched an at-home testing solution for Covid-19, after receiving Emergency Use Authorization (EUA) from the FDA.